awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q34297266-A0C8A84E-E199-4771-BE96-6DA95B828C06
Q34297266-A0C8A84E-E199-4771-BE96-6DA95B828C06
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34297266-A0C8A84E-E199-4771-BE96-6DA95B828C06
Relationship between time in therapeutic range and comparative treatment effect of rivaroxaban and warfarin: results from the ROCKET AF trial.
P2860
Q34297266-A0C8A84E-E199-4771-BE96-6DA95B828C06
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34297266-A0C8A84E-E199-4771-BE96-6DA95B828C06
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5aaaf21abb95c9c7ad907f6f803288b46ba7610e
P2860
Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation.